LINC00616 and periodontitis: Additionally, LINC00616 not only downregulates the expression of GPX4 and SLC7A11 but also targets miR-370, indirectly influencing and enhancing the levels of TFRC, thereby promoting the occurrence of ferroptosis, LINC00616 knockdown may be a promising therapeutic strategy for periodontitis [80].